Press Releases

Sep 17, 2026

Jordan Park

Press Releases

Shane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging Pharma

Cingulate Inc., a biopharmaceutical company developing next-generation products using its proprietary Precision Timed Release™ platform, announced that its Chairman & CEO and Chief Commercial Officer will present at the Indegene Digital Summit, focusing on rethinking pharmaceutical commercialization for emerging pharma companies. The company is pre…

CING

Sep 17, 2026

Leila Farooq

Press Releases

Hemab Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of HMB-003, an Investigational Therapy for the Management of Heavy Menstrual Bleeding

Hemab Therapeutics has initiated dosing of the first participant in its Phase 1 clinical trial for HMB-003, a novel peptide antifibrinolytic designed to manage heavy menstrual bleeding. HMB-003 aims to provide longer-lasting bleeding control with potential once-per-cycle dosing, addressing a significant unmet medical need. Initial study results are…

COAG

Sep 17, 2026

Jordan Park

Press Releases

NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution

NeOnc Technologies Holdings, Inc., a Nasdaq-listed clinical-stage biopharmaceutical company specializing in CNS cancer therapies, announced it has redeemed all outstanding Series A Convertible Preferred Stock for $6 million in cash. Funded by proceeds from a recent $15 million offering, this action eliminates potential dilution from the preferred s…

NTHI

Sep 17, 2026

Hana Yamamoto

Press Releases

Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026

Quince Therapeutics announces a virtual key opinion leader event on September 28, 2026, to highlight the current treatment landscape and explore the potential of LAM-001, an investigational once-daily inhaled formulation of rapamycin, in treating pulmonary hypertension associated with interstitial lung disease (PH-ILD) and bronchiolitis obliterans …

QNCX

Sep 17, 2026

Ajmal Hussain

Press Releases

Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum

Artiva Biotherapeutics, a clinical-stage biotech company focused on cell therapies for autoimmune diseases, announced its management will participate in the Stifel 2026 Virtual Immunology and Inflammation Forum. The company is initiating a Phase 3 registrational trial for its lead NK cell therapy, AlloNK, targeting refractory rheumatoid arthritis i…

ARTV

Sep 17, 2026

Ajmal Hussain

Press Releases

The Office Gurus Strengthens Executive Leadership Team to Accelerate Next Phase of Global Growth

The Office Gurus, a business segment of Superior Group of Companies (NASDAQ: SGC), announced key executive appointments aimed at accelerating global growth and scaling its technology-driven Experience Process Outsourcing platform. With extensive BPO and contact center leadership experience, the new executives will enhance operational excellence and…

SGC

Sep 17, 2026

Priya Menon

Press Releases

Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®

Adaptive Biotechnologies highlights the updated National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Multiple Myeloma, which now specifically endorse clonoSEQ as the FDA-cleared assay for minimal residual disease (MRD) testing with preferred sensitivity of 10^-6. The guidelines establish a dedicated framework for routine MR…

ADPT

Sep 17, 2026

Avery Klein

Press Releases

Rodman & Renshaw Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$8 Price Target

Quantum BioPharma Ltd., a Nasdaq-listed biopharmaceutical company focused on neurodegenerative and metabolic disorders, has been initiated with a BUY rating by Rodman & Renshaw alongside an $8 price target. The analyst coverage highlights Quantum's promising pipeline, specifically its lead compound Lucid-MS targeting multiple sclerosis, and its str…

QNTM

Sep 17, 2026

Derek Hwang

Press Releases

ZenaTech Selected for Canada's Defence Drone Initiative Marketplace, Expanding Opportunities for ZenaDrone's AI-Powered Autonomous Drone Solutions

ZenaTech, Inc., a Nasdaq-listed US technology company specializing in AI-powered autonomous drones, has been selected as a qualified supplier under Canada's Defence Drone Initiative Marketplace. This inclusion allows ZenaTech to compete for upcoming defense and security drone contracts supporting the Canadian Armed Forces and Canadian Coast Guard. …

ZENA

Sep 17, 2026

Priya Menon

Press Releases

Hallador Secures Up to $675 Million Debt Financing for Turtle Creek Gas

Hallador Energy Company closed a $600 million senior secured loan plus $75 million revolving credit facility, forming up to $675 million in financing to cover most capital expenses for its Turtle Creek Gas project, a new 460-megawatt natural gas power plant expected to cost under $800 million. The company plans to repay existing debt and advance co…

HNRG

Sep 17, 2026

Caleb Monroe

Press Releases

Westwood Launches Westwood Salient Enhanced Power & Infrastructure ETF (PWRX), the First ETF to Launch on the Texas Stock Exchange

Westwood Holdings Group has introduced the Westwood Salient Enhanced Power & Infrastructure ETF (PWRX), the first ETF to debut on the Texas Stock Exchange. This actively managed ETF focuses on companies involved in the expanding power ecosystem including traditional energy, utilities, grid, and data center infrastructure, aiming to capitalize on ri…

PWRX

Sep 17, 2026

Ajmal Hussain

Press Releases

Catheter Precision Expands LockeT Commercialization Across Latin America Following Successful Launch in Brazil

Catheter Precision Inc., a U.S.-based medical device company specializing in cardiac electrophysiology, has expanded commercialization of its LockeT wound closure device across Latin America following a successful launch in Brazil. Since August 2026, LockeT has been adopted by six hospitals in Brazil, with further expansion plans targeting Argentin…

VTAK

Sep 17, 2026

Maya Rios

Press Releases

Two-Thirds of American Homeowners Have Experienced a Power Outage This Year, Majority Worry Power Outages Will Become More Common

Sunrun Inc. released survey results revealing that two-thirds of American homeowners experienced power outages in 2026 and many anticipate more frequent outages going forward. Highlighting homeowner concerns about grid reliability and weather-related disruptions, Sunrun promotes its home battery storage and solar energy systems as solutions for ene…

RUN

Sep 17, 2026

Jordan Park

Press Releases

GCL Global Holdings Ltd. Announces Transfer of Listing to The Nasdaq Capital Market and Additional 180 Days to Cure Minimum Bid Price Deficiency

GCL Global Holdings Ltd., a provider of games and entertainment focused on the Asian gaming market, announced its ordinary shares will transfer to The Nasdaq Capital Market effective September 18, 2026. The company received an additional 180-day extension until March 15, 2027, to cure a deficiency related to Nasdaq's minimum bid price rule. The tra…

GCL

Sep 17, 2026

Jordan Park

Press Releases

Genius Group to Release Half Year 2026 Results on September 28, 2026

Genius Group Limited (NYSE American: GNS), a global AI-powered education company, will release its half year 2026 financial results on September 28, 2026. The company will also provide updates on its AI-Powered Genius School, Genius Academy, Genius Resorts, Genius City model, Dual Treasury strategy, and current legal matters. Results are prepared o…

GNS

Sep 17, 2026

Sofia Navarro

Press Releases

Aduro Among 10 Companies Invited to Present at PepsiCo Sustainability Innovation Hub 2026

Aduro Clean Technologies Inc. announced it has been invited to present its Hydrochemolytic™ Technology (HCT) at the PepsiCo Sustainability Innovation Hub 2026. The presentation will focus on chemical recycling solutions for complex polyolefin-rich flexible films and multilayer packaging, highlighting Aduro's ongoing collaboration with ECOCE in Mexi…

ADUR

Sep 17, 2026

Derek Hwang

Press Releases

Apollo Provides $1.25 Billion Capital Solution to Support Combination of BMG and Concord

Apollo Global Management has provided a $1.25 billion equity capital solution to support the combination of music companies BMG and Concord. Apollo acquired a minority interest in BMG's subsidiary holding the Concord ABS music catalog, enabling BMG to repay outstanding asset-backed securities liabilities. This partnership underscores Apollo's expan…

APO

Sep 17, 2026

Leila Farooq

Press Releases

Quantum X Labs Launches Quantum-Native Cybersecurity Program Designed to Harness Quantum Properties for Next-Generation Security

Quantum X Labs Inc. has launched QuantumQ Security, a new multi-dimensional quantum-native cybersecurity architecture program focusing on Detect, Encrypt, and Verify dimensions. This novel approach integrates quantum mechanical properties into cybersecurity, diverging from traditional methods that merely adapt classical security for quantum threats…

QXL

Sep 17, 2026

Jordan Park

Press Releases

Beam Global and Masdar City Free Zone Sign MOU to Explore Sustainable Energy Infrastructure Opportunities

Beam Global, a Nasdaq-listed sustainable technology innovator, entered a Memorandum of Understanding with Masdar City Free Zone to explore integration of its smart energy and clean mobility technologies within the Masdar City ecosystem. The collaboration focuses on deploying off-grid EV charging infrastructure, solar-integrated e-bikes, and other c…

BEEM

Sep 17, 2026

Maya Rios

Press Releases

Firefly Neuroscience’s Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial’s AI-Native Operating System for Brain Medicine

Firefly Neuroscience has announced a strategic collaboration with Radial to integrate Firefly’s FDA 510(k)-cleared Evoke AI-powered EEG/ERP technology into Radial's AI-native operating system for brain medicine, RadialOS. This integration aims to provide objective brain function data to improve diagnosis, personalize treatment pathways, and monitor…

AIFF

Sep 17, 2026

Derek Hwang

Press Releases

Clearmind Medicine Delivers Briefing to FDA Following Invitation to Historic Psychedelic Hearing in Washington, D.C.

Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage biopharmaceutical company, presented at the FDA's first-ever dedicated psychedelic hearing, discussing patient access to their non-hallucinogenic psychedelic-derived neuroplastogen treatments. Their lead candidate, MEAI, is in FDA-approved Phase 2a trials at Yale and Johns Hopkins for Alcohol…

CMND

Sep 17, 2026

Priya Menon

Press Releases

Rail Vision Launches YardFlow™, its Leading AI Perception Solution for Industrial and Freight Railyard Operations

Rail Vision Ltd. announced the launch of YardFlow™, a new AI-driven perception solution designed for diverse industrial and freight railyard environments. The system enhances real-time hazard detection using advanced sensors and deep-learning algorithms, supporting safer and more efficient rail operations. YardFlow also bolsters Rail Vision's ongoi…

RVSN

Sep 17, 2026

Priya Menon

Press Releases

KALA BIO Adds Healthcare Operator Yenvy Truong to Advisory Team

KALA BIO appoints Yenvy Truong, an experienced healthcare operator and founder of The LSM Group, to its advisory team. Ms. Truong will aid in scaling existing business operations, exploring acquisition opportunities, and expanding KALA’s footprint in diagnostics, genetic testing, and AI-enhanced preventive health. This move aligns with the company'…

KALA

Sep 17, 2026

Nina Shah

Press Releases

Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026

Fennec Pharmaceuticals announced successful Phase 2 STS-J01 clinical trial results demonstrating PEDMARK® significantly reduces cisplatin-induced hearing loss in pediatric and young adult cancer patients in Japan, with strong tumor response rates and favorable safety profile. Results support delayed six-hour administration of PEDMARK®, bolstering i…

FENC

Sep 17, 2026

Ajmal Hussain

Press Releases

Atlanticus Completes Sale of CAR Auto Finance Operations

Atlanticus Holdings Corporation completed the sale of its CAR Auto Finance operations for approximately $71.2 million, exiting the auto finance segment. The company plans to use the proceeds to reduce debt and invest in higher-growth consumer credit products where it sees long-term value. This strategic shift aims to concentrate resources on expand…

ATLC